Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Assessing Feasibility of a Focused Geriatric Assessment in Older Adults with Sickle Cell Disease to Address Functional Risk Factors for Morbidity and Mortality

Charity I Oyedeji, MD, Carl Pieper, PhD, Katherine Hall, PhD, Miriam Morey, PhD, Heather Whitson, MD MHS, John J. Strouse, MD, PhD

Blood (2019) 134 (Supplement_1): 518.

https://doi.org/10.1182/blood-2019-122634

Published: 2019

Journal Articles

Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Shannon R. McCurdy, MD, Shannon H. Gier, BS, Daria V. Babushok, MD PhD, Noelle V. Frey, MD, Saar I. Gill, MD PhD, Elizabeth O. Hexner, MD, Alison W. Loren, MD MSCE, James K. Mangan, MD PhD, Mary Ellen Martin, MD, Alexander E. Perl, MD, Ivan Maillard, MD PhD, Keith W. Pratz, MD, David L. Porter, MD, Martin P. Carroll, MD, Phyllis A. Gimotty, PhD, Selina M. Luger, MD FRCPC

Blood (2019) 134 (Supplement_1): 2209.

https://doi.org/10.1182/blood-2019-124468

Published: 2019

Journal Articles

Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment

Hira S Mian, MD, Gregory R Pond, PhD PStat, Sascha A Tuchman, MD, Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI

Blood (2019) 134 (Supplement_1): 4774.

https://doi.org/10.1182/blood-2019-122261

Published: 2019

Journal Articles

Pilot Study on Frailty and Functionality on Routine Clinical Assessment in Allogeneichematopoietic Cell Transplantation to Predict Outcomes

Maria Queralt Salas, MD, Eshetu G Atenafu, M.Sc., P.Stat, Ora Bascom, Allo-HSCT Coordinator, Leeann Wilson, RN, BSc, BSc N(HON), CON(c), Arjun Law, MDDM, Wilson Lam, MD, David Loach, MD, Zeyad Al-Shaibani, Fotios V. Michelis, MD PhD, Dennis Dong Hwan Kim, MD PhD, Jeffrey H. Lipton, MD PhD, Auro Viswabandya, MDDM, Jonas Mattsson, MD, Alibhai M.H. Shabbir, MD, Rajat Kumar, MD

Blood (2019) 134 (Supplement_1): 380.

https://doi.org/10.1182/blood-2019-126071

Published: 2019

Journal Articles

Prognostic Value of Disease Risk Score Versus Gait Speed in Older Adults with Lymphoma

Lee Mozessohn, MD, Liying Zhang, PhD, Oreofe O. Odejide, MD MPH, Anna M. Tanasijevic, MPH, Richard Chen, BA, Rena Buckstein, MD FRCPC, Robert J. Soiffer, MD, Jorge J Castillo, MD, Andrew Keezer, BS, Jane Driver, MD MPH, Gregory A. Abel, MDMPH

Blood (2019) 134 (Supplement_1): 68.

https://doi.org/10.1182/blood-2019-124946

Published: 2019

Journal Articles

Calpain-1 Contributes to Pain and Organ Damage in Sickle Cell Disease

Stacy B Kiven, BS, Jianxun Lei, PhD, Varun Sagi, BS, Huy Tran, BS, Ying Wang, PhD, Piyusha P Pagare, PhD, Jennifer O Nwankwo, PhD, Nils Lambrecht, MD PhD, Kalpna Gupta, PhD

Blood (2019) 134 (Supplement_1): 76.

https://doi.org/10.1182/blood-2019-127761

Published: 2019

Journal Articles

Make time for gait speed: vital to staging the aging

Tanya M. Wildes

Blood (2019) 134 (4): 334–336.

https://doi.org/10.1182/blood.2019001335

Published: 2019

Journal Articles

Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies

Michael A. Liu, Clark DuMontier, Anays Murillo, Tammy T. Hshieh, Jonathan F. Bean, Robert J. Soiffer, Richard M. Stone, Gregory A. Abel, Jane A. Driver

Blood (2019) 134 (4): 374–382.

https://doi.org/10.1182/blood.2019000758

Published: 2019

Includes: Supplemental data

Journal Articles

Geriatric Assessment (GA) Measures and Patient-Reported Outcomes (PROs) Among Older Adults Treated in a Phase 1b Study for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Heidi D. Klepin, MD MS, Avrita Campinha-Bacote, Wan-Jen Hong, Patrick Phuong, Jue Wang, Mehrdad Mobasher, MD MPH, Peter Trask

Blood (2018) 132 (Supplement 1): 4076.

https://doi.org/10.1182/blood-2018-99-116038

Published: 2018

Journal Articles

A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies

Takahiro Kamiya, Kota Mizuno, Shinji Ogura, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa, Tomonori Nakazato, MD PhD

Blood (2018) 132 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2018-99-114545

Published: 2018

Journal Articles

Functional Predictors of Chemotherapy Toxicity in Elderly Lymphoma Patients: A Prospective Pilot Study

Anca Prica, MD, Vinita Dhir, Manjula Maganti, MSc, Vishal Kukreti, MD, John Kuruvilla, MD, Michael Crump

Blood (2018) 132 (Supplement 1): 4843.

https://doi.org/10.1182/blood-2018-99-115400

Published: 2018

Journal Articles

Comprehensive Geriatric Assessment in Elderly Patients with Aggressive Non-Hodgkin Lymphoma in Peru

Brady E. Beltrán, MD, Rodrigo Motta, MD, María P. Gamarra, MD, Roger Araujo, MD, Jorge J. Castillo, MD

Blood (2018) 132 (Supplement 1): 2307.

https://doi.org/10.1182/blood-2018-99-113238

Published: 2018

Journal Articles

Spliceosome Mutations Are Associated with Frailty in Older Patients with Myeloid Malignancies

Marlise R. Luskin, MD, Angel M. Cronin, MS, Kevin Copson, MA, Wooram Jung, Martha Wadleigh, MD, Daniel J. DeAngelo, MD, David P. Steensma, MD, Jane Driver, MD MPH, Andrew A. Lane, MD PhD, R. Coleman Lindsley, MD PhD, Gregory A. Abel, MD

Blood (2017) 130 (Supplement 1): 4276.

https://doi.org/10.1182/blood.V130.Suppl_1.4276.4276

Published: 2017

Journal Articles

Feasibility and Efficacy of Dose Adjusted Melphalan - Prednisone - Bortezomib (MPV) in Elderly Patients ≥ 75 Years of Age with Newly Diagnosed Multiple Myeloma; the Non-Randomised Phase II HOVON 123 Study

Sonja Zweegman, MD PhD, Mark-David Levin, MD PhD, Saskia K. Klein, MD PhD, Esther G.M. De Waal, MD, Corien M. Eeltink, RN, MA, ANP, Paula F. Ypma, MD, Amanda C. Dijk, MD, Matthijs Westerman, MD, Wendy Deenik, MD PhD, Bea Tanis, MD PhD, Monique S. Slee-Valentijn, MD, Monique Minnema, Heleen Visser-Wisselaar, PhD, Claudia Stege, MD, Niels W.C.J. van de Donk, MD PhD, Kazem Nasserinejad, MA, Pieter Sonneveld, MD PhD

Blood (2016) 128 (22): 3305.

https://doi.org/10.1182/blood.V128.22.3305.3305

Published: 2016

Journal Articles

High Mobility Group A1 Chromatin Remodeling Protein Regulates Self-Renewal, Niche Formation, and Regenerative Function in Adult Stem Cells through Wnt/β-Catenin Signaling

Linda Resar, MD, Lingling Xian, MD PhD, Tait Huso, Amy Belton, PhDBSc, Leslie Cope, PhDBSc, David Huso, DVM, PhD

Blood (2016) 128 (22): 2647.

https://doi.org/10.1182/blood.V128.22.2647.2647

Published: 2016

Journal Articles

Measurement and Prevalence of Cognitive Impairment in Older Patients with Hematologic Malignancies

Tammy T. Hshieh, MD MPH, Nolan B. Condron, BA, Richard M. Stone, MD, Robert J. Soiffer, MD, Gregory A. Abel, MD MPH

Blood (2016) 128 (22): 689.

https://doi.org/10.1182/blood.V128.22.689.689

Published: 2016

Journal Articles

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD MS, Can-Lan Sun, PhD, Kirsten K. Ness, PhD, Jennifer Berano Teh, MD, Jessica Wu, Liton F. Francisco, BS, Saro Armenian, DO, MPH, Amy Schad, MPH, CCRP, Golnaz Namdar, MPH, Alysia Bosworth, Linus Kuo, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2015) 126 (23): 739.

https://doi.org/10.1182/blood.V126.23.739.739

Published: 2015

Journal Articles

Feasibility of Routine Frailty Screening Assessment for Patients in a Hematologic Oncology Clinic: Results from a Pilot Study

Gregory A. Abel, MD MPH, Tammy T. Hshieh, MD, Nolan B. Condron, Caron A. Jacobson, MD, David P. Steensma, MD, Jacob P. Laubach, MD, Richard M. Stone, MD, Jane A. Driver, MD MPH

Blood (2015) 126 (23): 3306.

https://doi.org/10.1182/blood.V126.23.3306.3306

Published: 2015

Journal Articles

Impact of Frailty on Hematopoietic Cell on Early Transplant Outcomes in Older Recipients

Mukta Arora, MD, Smita Bhatia, MD MPH, Todd E. DeFor, MS, Manju Nayar, Hewan Belete, MDcal student, Troy Lund, MD PhD, Bharat Thyagarajan, MDPhD, Celalettin Ustun, MD, Daniel Weisdorf, MD

Blood (2015) 126 (23): 388.

https://doi.org/10.1182/blood.V126.23.388.388

Published: 2015

Journal Articles

Geriatric Assessment Predicts Overall Survival Among Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia.

Heidi D. Klepin, MD, MS, Janet A. Tooze, PhD, Ann M. Geiger, PhD, Stephen Kritchevsky, PhD, Jeff Williamson, MD, MHS, Leslie R. Ellis, MD, Denise Levitan, MD, Timothy Pardee, MD, PhD, Scott Isom, MS, Bayard L. Powell, MD

Blood (2010) 116 (21): 1535.

https://doi.org/10.1182/blood.V116.21.1535.1535

Published: 2010

NARROW

Assessing Feasibility of a Focused Geriatric Assessment in Older Adults with Sickle Cell Disease to Address Functional Risk Factors for Morbidity and Mortality

Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment

Pilot Study on Frailty and Functionality on Routine Clinical Assessment in Allogeneichematopoietic Cell Transplantation to Predict Outcomes

Prognostic Value of Disease Risk Score Versus Gait Speed in Older Adults with Lymphoma

Calpain-1 Contributes to Pain and Organ Damage in Sickle Cell Disease

Make time for gait speed: vital to staging the aging

Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies

Geriatric Assessment (GA) Measures and Patient-Reported Outcomes (PROs) Among Older Adults Treated in a Phase 1b Study for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies

Functional Predictors of Chemotherapy Toxicity in Elderly Lymphoma Patients: A Prospective Pilot Study

Comprehensive Geriatric Assessment in Elderly Patients with Aggressive Non-Hodgkin Lymphoma in Peru

Spliceosome Mutations Are Associated with Frailty in Older Patients with Myeloid Malignancies

Feasibility and Efficacy of Dose Adjusted Melphalan - Prednisone - Bortezomib (MPV) in Elderly Patients ≥ 75 Years of Age with Newly Diagnosed Multiple Myeloma; the Non-Randomised Phase II HOVON 123 Study

High Mobility Group A1 Chromatin Remodeling Protein Regulates Self-Renewal, Niche Formation, and Regenerative Function in Adult Stem Cells through Wnt/β-Catenin Signaling

Measurement and Prevalence of Cognitive Impairment in Older Patients with Hematologic Malignancies

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Feasibility of Routine Frailty Screening Assessment for Patients in a Hematologic Oncology Clinic: Results from a Pilot Study

Impact of Frailty on Hematopoietic Cell on Early Transplant Outcomes in Older Recipients

Geriatric Assessment Predicts Overall Survival Among Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only